Viewing StudyNCT04960202



Ignite Creation Date: 2024-05-06 @ 4:22 PM
Last Modification Date: 2024-10-26 @ 2:08 PM
Study NCT ID: NCT04960202
Status: COMPLETED
Last Update Posted: 2023-02-09
First Post: 2021-07-10

Brief Title: EPIC-HR Study of Oral PF-07321332Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19
Sponsor: Pfizer
Organization: Pfizer

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-07-16
Start Date Type: ACTUAL
Primary Completion Date: 2021-12-09
Primary Completion Date Type: ACTUAL
Completion Date: 2022-04-25
Completion Date Type: ACTUAL
First Submit Date: 2021-07-10
First Submit QC Date: July 10 2021
Study First Post Date: 2021-07-13
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2023-02-09
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-01-13
Last Update Post Date: 2023-02-09
Last Update Post Date Type: ACTUAL